1I3P
THE 3.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF A MUTATED BACULOVIRUS P35 AFTER CASPASE CLEAVAGE
1I3P の概要
| エントリーDOI | 10.2210/pdb1i3p/pdb |
| 関連するPDBエントリー | 1p35 |
| 分子名称 | EARLY 35 KDA PROTEIN (1 entity in total) |
| 機能のキーワード | helix-turn-helix, reactive site loop, hairpin loop, apoptosis |
| 由来する生物種 | Autographa californica nucleopolyhedrovirus |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 34712.43 |
| 構造登録者 | dela Cruz, W.P.,Lemongello, D.,Friesen, P.D.,Fisher, A.J. (登録日: 2001-02-15, 公開日: 2001-10-24, 最終更新日: 2023-08-09) |
| 主引用文献 | dela Cruz, W.P.,Friesen, P.D.,Fisher, A.J. Crystal structure of baculovirus P35 reveals a novel conformational change in the reactive site loop after caspase cleavage. J.Biol.Chem., 276:32933-32939, 2001 Cited by PubMed Abstract: Baculovirus P35 is a universal suppressor of apoptosis that stoichiometrically inhibits cellular caspases in a novel cleavage-dependent mechanism. Upon caspase cleavage at Asp-87, the 10- and 25-kDa cleavage products of P35 remain tightly associated with the inhibited caspase. Mutations in the alpha-helix of the reactive site loop preceding the cleavage site abrogate caspase inhibition and antiapoptotic activity. Substitution of Pro for Val-71, which is located in the middle of this alpha-helix, produces a protein that is cleaved at the requisite Asp-87 but does not remain bound to the caspase. This loss-of-function mutation provided the opportunity to structurally analyze the conformational changes of the P35 reactive site loop after caspase cleavage. We report here the 2.7 A resolution crystal structure of V71P-mutated P35 after cleavage by human caspase-3. The structure reveals a large movement in the carboxyl-terminal side of the reactive site loop that swings down and forms a new beta-strand that augments an existing beta-sheet. Additionally, the hydrophobic amino terminus releases and extends away from the protein core. Similar movements occur when P35 forms an inhibitory complex with human caspase-8. These findings suggest that the alpha-helix mutation may alter the sequential steps or kinetics of the conformational changes required for inhibition, thereby causing P35 loss of function. PubMed: 11402050DOI: 10.1074/jbc.M103930200 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (3.1 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






